[HTML][HTML] SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients …

J Bruminhent, C Setthaudom, P Chaumdee… - American Journal of …, 2022 - Elsevier
Immunogenicity following inactivated SARS-CoV-2 vaccination among solid organ
transplant recipients has not been assessed. Seventy-five patients (37 kidney transplant [KT] …

Emergence of SARS-CoV-2 spike mutations during prolonged infection in immunocompromised hosts

KKK Ko, H Yingtaweesittikul, TT Tan… - Microbiology …, 2022 - Am Soc Microbiol
Immunocompromised hosts with prolonged severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infections have been implicated in the emergence of highly mutated SARS …

Freshwater fungal biology

MS Calabon, KD Hyde, EBG Jones, DF Bao… - …, 2023 - estudogeral.uc.pt
Research into freshwater fungi has generated a wealth of information over the past decades
with various published articles, ie, reviews, books, and monographs. With the advancement …

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients

J Bruminhent, C Setthaudom, R Kitpermkiat… - Scientific reports, 2022 - nature.com
Vaccination with inactivated SARS-CoV-2 virus produces suboptimal immune responses
among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients …

The impact of the COVID-19 pandemic on mortality in people with dementia without COVID-19: a systematic review and meta-analysis

M Axenhus, KS Frederiksen, RZ Zhou, G Waldemar… - BMC geriatrics, 2022 - Springer
Introduction Significant mortality amongst vulnerable populations, such as people living with
dementia, might go undetected during pandemic conditions due to refocus of care efforts …

Predicting severe outcomes in Covid-19 related illness using only patient demographics, comorbidities and symptoms

C Ryan, A Minc, J Caceres, A Balsalobre, A Dixit… - The American journal of …, 2021 - Elsevier
Objective Development of a risk-stratification model to predict severe Covid-19 related
illness, using only presenting symptoms, comorbidities and demographic data. Materials …

DEspRhigh neutrophils are associated with critical illness in COVID-19

JT deKay, IF Emery, J Rud, A Eldridge, C Lord… - Scientific reports, 2021 - nature.com
SARS-CoV-2 infection results in a spectrum of outcomes from no symptoms to widely
varying degrees of illness to death. A better understanding of the immune response to SARS …

Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection

E Khatamzas, MH Antwerpen, A Rehn, A Graf… - Nature …, 2022 - nature.com
Antibodies against the spike protein of severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) can drive adaptive evolution in immunocompromised patients with chronic …

Risk factors associated with COVID-19 outcomes among people with intellectual and developmental disabilities receiving residential services

SD Landes, MA Turk, MR Damiani, P Proctor… - JAMA Network …, 2021 - jamanetwork.com
Importance Although there is evidence of more severe COVID-19 outcomes, there is no
information describing the risk factors for COVID-19 diagnosis and/or mortality among …

Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis

MM Mehrabi Nejad, P Shobeiri, H Dehghanbanadaki… - Virology journal, 2022 - Springer
Background Immunocompromised (IC) patients are at higher risk of more severe COVID-19
infections than the general population. Special considerations should be dedicated to such …